The course of cancer-related insomnia: don't expect it to disappear after cancer treatment
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The study aimed to examine the 12-month course of cancer-related insomnia (CRI) and to identify possible predictors for the prevalence and persistence of CRI. METHODS This longitudinal multicenter study included N = 405 patients with cancer (56% females, mean age: 58.6 years). CRI was measured by the Insomnia Severity Index (ISI). Socio-demographic and clinical data, as well as psychological parameters (Distress Thermometer, PHQ-9, GAD-7, and EORTC-Fatigue), were assessed at baseline (T1) and 12 months later (T2). RESULTS In our sample, a high prevalence of relevant insomnia symptoms (49.4%, ISI > 7) was found, while a clinical insomnia diagnosis was verified in 12.8% (ISI > 14). When insomnia was present at T1, this problem was persistent after one year in 64%. At T2, however, significantly more women suffered from insomnia symptoms (53.3% women vs. 39.3% men; p = 0.003). Insomnia was associated with many clinical and psychological parameters, especially with fatigue (r = 0.5). Multiple regression analysis revealed that, in women, only insomnia at T1 was a significant predictor for insomnia at T2 (R2 = 0.40; F(5) = 12.5; p < 0.001), whereas in men insomnia, depressive symptoms and the use of psychotropic drugs at T1 predicted the extent of insomnia at T2 (R2 = 0.28; F(7) = 9.5; p < 0.001). In all participants, levels of distress, depression, and anxiety decreased from T1 to T2 (p's < 0.016). CONCLUSION Insomnia is a common disorder in cancer patients. Although medical and psychological parameters improved during the 12-month course of cancer treatment, our results show that insomnia is highly persistent, especially in women. This indicates that adequate support for those affected is needed. CLINICAL TRIAL REGISTRATION NUMBER DRKS00004860.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Validation of the Insomnia Severity Index as an outcome measure for insomnia research
Bastien, C. (2001) · Sleep Medicine · doi:10.1016/s1389-9457(00)00065-4 · Cited by 8,067
International Classification of Sleep Disorders-Third Edition
Sateia, M. J. (2014) · Chest · doi:10.1378/chest.14-0970 · Cited by 3,860
Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.01.011 · Cited by 2,779
European guideline for the diagnosis and treatment of insomnia
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., Espie, C. A., Garcia‐Borreguero, D., Gjerstad, M., Gonçalves, M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12594 · Cited by 2,049
The hyperarousal model of insomnia: A review of the concept and its evidence
Riemann, D., Spiegelhalder, K., Feige, B., Voderholzer, U., Berger, M., Perlis, M., & Nissen, C. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.04.002 · Cited by 1,789
Cost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
Insomnia and risk of cardiovascular disease: a meta-analysis
Sofi, F., Cesari, F., Casini, A., Macchi, C., Abbate, R., & Gensini, G. F. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487312460020 · Cited by 713
Anothaisintawee, T., Reutrakul, S., Van Cauter, E., & Thakkinstian, A. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.10.002 · Cited by 640
One in two cancer patients is significantly distressed: Prevalence and indicators of distress
Mehnert, A., Hartung, T. J., Friedrich, M., Vehling, S., Brähler, E., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., et al. (2018) · Psycho-Oncology · doi:10.1002/pon.4464 · Cited by 615
Self-citation
Cited by
Prevalence of sleep disturbance in patients with cancer: a systematic review and meta-analysis
Al Maqbali, M., Al Sinani, M., Alsayed, A., & Gleason, A. M. (2022) · Clinical Nursing Research · doi:10.1177/10547738221092146 · Cited by 167
Evaluation and management of insomnia in women with breast cancer
Kwak, A., Jacobs, J., Haggett, D., Jimenez, R., & Peppercorn, J. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05635-0 · Cited by 107
Squires, L. R., Rash, J. A., Fawcett, J., & Garland, S. N. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101615 · Cited by 85
Living with persistent insomnia after cancer: A qualitative analysis of impact and management
Reynolds‐Cowie, P., & Fleming, L. (2021) · British Journal of Health Psychology · doi:10.1111/bjhp.12446 · Cited by 53
“Evidence suggests that clinicians perceive themselves to be inadequately trained or qualified to assess and treat sleep disturbance in cancer patients, reducing the likelihood that it will be on the agenda during clinic appointments (Johnson et al., 2016; Schieber et al., 2019).”
BackgroundResultInfluentialGarland, S. N., Tulk, J., Savard, J., Rash, J. A., Browne, S., Urquhart, R., Seal, M., Thoms, J., & Laing, K. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02330 · Cited by 29
Metadata
- Authors
- Schieber, K., Niecke, A., Geiser, F., Erim, Y., Bergelt, C., Büttner-Teleaga, A., Maatouk, I., Stein, B., Teufel, M., Wickert, M., Wuensch, A., & Weis, J.
- Venue
- Sleep Medicine
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 58
- Pages
- 107-113
- ISSN
- 1389-9457 (ISSN-L)
- OpenAlex
- W2922271713
- Cited by
- 72
- References
- 12
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The course of cancer-related insomnia: don't expect it to disappear after cancer treatment. https://app.cochat.ai/papers/10.1016/j.sleep.2019.02.018
- The paper
- Schieber, K., Niecke, A., Geiser, F., Erim, Y., Bergelt, C., Büttner-Teleaga, A., Maatouk, I., Stein, B., Teufel, M., Wickert, M., Wuensch, A., & Weis, J. (2019). The course of cancer-related insomnia: don't expect it to disappear after cancer treatment. Sleep Medicine. https://doi.org/10.1016/j.sleep.2019.02.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.